Susan Hurst

Assessment of three human in vitro systems in the generation of major human excretory and circulating metabolites.

Deepak Dalvie, Angus Nedderman, R Scott Obach, 2009, Chemical research in toxicology.

Application of CYP3A4 in vitro data to predict clinical drug-drug interactions; predictions of compounds as objects of interaction.

Alex Phipps, R Scott Obach, Maurice Dickins, 2008, British journal of clinical pharmacology.

Biosimilars: Practical Considerations for Pharmacists

James G. Stevenson, R. Popovian, J. Stevenson, 2017, The Annals of pharmacotherapy.

DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS

Barry C. Jones, Jeffrey R. Koup, Dennis A. Smith, 2004, Drug Metabolism and Disposition.

Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction

Alex Phipps, Kuresh Youdim, Maurice Dickins, 2009, Drug Metabolism and Disposition.

Quantitative prediction of renal transporter-mediated clinical drug-drug interactions.

Bo Feng, Brian Corrigan, Ayman El-Kattan, 2013, Molecular pharmaceutics.

Key considerations in the preclinical development of biosimilars.

Carol F. Kirchhoff, A. Ryan, Susan Hurst, 2015, Drug discovery today.

Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans.

Ayman El-Kattan, C. Loi, A. El‐Kattan, 2007, Expert opinion on drug metabolism & toxicology.